BBC/
Final clinical trials for a corona-virus vaccine, developed by AstraZeneca and Oxford University have been put on hold after a participant had a suspected adverse reaction in the UK.
AstraZeneca described the development as a ‘routine’ pause in the case of ‘an unexplained illness’.
The outcome of vaccine trials is being closely monitored around the world.
The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.
Hopes have been high that the vaccine might be one of the first to come on the market, following successful phase 1 and 2 testing.
Its move to Phase 3 testing has involved some 30, 000 participants in the US as well as in the UK, Brazil, and South Africa. Phase 3 trials in vaccines often involve thousands of participants and can last several years.
0Segun Atanda/ The Nigerian National Petroleum Company Limited (NNPC Ltd) has refuted claims made by…
Segun Atanda/ A digital storm is sweeping through the corridors of power in Africa, and…
Malik Yahya/ The Special Adviser to the President on Media and Publicity to President Bola…
Culled from The Daily Muck/ They traveled thousands of miles, filled with hope for a…
Segun Atanda/ President Bola Tinubu today, in Beijing, China, emphasized the critical role of global…
Matilda Omonaiye/ The Nigerian Consumer Credit Corporation (CREDICORP) has officially launched its nationwide consumer credit…